Article Text

Download PDFPDF

502 The epigenetics of the now known 330 lupus genetic risk loci in two ancestries are independently consonant with causal regulatory mechanisms involving epstein-barr virus (EBV)-encoded transcription co-factors expressed in EBV-infected, EBV latency III-expressing B cells (LCLs)
  1. Viktoryia Laurynenka1,2,
  2. Xiaoting Chen2,
  3. Sreeja Parameswaran2,
  4. Leah C Kottyan2,3,
  5. Matthew T Weirauch2,3,
  6. Iouri Chepelev1,
  7. Kenneth M Kaufman1,2 and
  8. John B Harley1,4
  1. 1Research Service, US Department of Veterans Affairs Medical Center, Cincinnati, Ohio, USA
  2. 2Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children’s Hospital Med. Cen., Cincinnati, Ohio, USA
  3. 3Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
  4. 4Cincinnati Education and Research for Veterans Foundation (CERVF), Cincinnati, Ohio USA

Abstract

Background Multiple desperate results support the host immune response to Epstein-Barr virus (EBV) infection as a causal etiology for lupus with evidence supporting autoantibody generation through a molecular mimicry mechanism originating from EBNA1 (Panel A). If true, then this conclusion would be supported by independent tests. We asked whether the epigenetics of lupus in East Asian (EAS) and European (EU) ancestries would independently support this hypothesis, given their large number of now identified risk loci.

Methods Literature review identified SLE risk loci at p<5x10–8 under quality control. We curated 18,075 ChIP- seq datasets for 1,339 transcription factors and co-factors (TFs) (9,862 datasets) and 81 histone marks (HMs) (8,213 datasets), from 3,531 cellular types, evaluated with modified RELI and MARIO from PMID: 2966164.

Results 330 SLE risk loci with p<5x10–8 were published prior to 2023. KEGG analysis of the 330 loci shows strong associations with IFNγ, IL-12, IL-23, B-cell receptor, & EBV (6.1<OR<16, 10–30<pa<10–8). Of the 330 loci, 255 are found in East Asians (EAS) and 106 in Europeans (EU), with fewer in other ancestries. At p<5x10–8, only 40 loci are shared by EAS & EU. Evaluating ChIP-seq datasets separately in EAS & EU, reveals that 200 (14.9%) of 1,339 tested TFs found in 1,871 (19.0%) of the 9,862 TF ChIP-seq datasets are associated with SLE loci at p<10–6 in both ancestries. The TF dataset associations are highly similar in EAS & EU (r=0.73 (Spearman), p<0.0001) (Panel B). TF DNA binding at SLE loci in EBV-infected B cells is enriched relative to other cell types in both EAS & EU (OR>19, p<10–300). Removing the SLE risk loci separately in EAS & EU bound by the EBV-encoded EBNA2, EBNA3C, and EBNALP TFs reduces the significantly associated human TF datasets at p<10–6 by >95%, as is also found by removing the loci bound by many human-encoded TFs.

Of the associated host DNA binding of TFs at p<10–6, EBNA2, EBNALP, & EBNA3C, all EBV-encoded Latency III expression products, are separately associated (2.1<OR<2.6, p<10–11) with the SLE risk loci in both EAS & EU ancestries (Panel C). At OR>3.2, p≤10–4, human TFs, known to form super-enhancers in EBV-infected, Latency III expressing transformed B cells (LCLs), are enriched compared to uninfected B cells independently at the EAS & EU loci.

Of the 81 HM types, H3K27ac and H3K36me3 are the most closely associated with both the EAS & EU SLE loci (2.43<OR<2.6, 10–56<p<10–24 and 2.55<OR<2.73, 10–56<p<10–34), binding a majority (>66%) of EAS & EU SLE loci (Panel C). The same pattern of significant association for H3K27ac as found in LCLs, is found in other cell types, but the proportion of significant H3K27ac and H3K36me3 LCL datasets is far higher than any other cell type (125<OR<882, 10–14<p<10–10), including compared to B cells that are not EBV-infected (45<OR<248, 10–4<p<10–5). >60% of both EAS & EU SLE loci are bound by H3K27ac or H3K36me3 more frequently in LCLs than in B cells that are not EBV-infected.

H3K27ac and H3K36me3 DNA binding is distorted at heterozygotes for 58 & 16 EAS loci and 44 & 18 EU loci (by MARIO with score>0.4).

Conclusions These results complement previous conclusions that the host response to EBV infection generates autoantibodies in lupus, by showing that histone marks, H3K27ac and H3K36me3, possibly poise chromatin to support the regulatory changes induced by the SLE risk variants in EBV-infected B cells expressing Latency III EBV-encoded TFs (LCLs). These findings are independently present in the genetic mechanisms altering the risk of lupus for both EAS and EU ancestries, therefore, potentially important in the pathogenesis of lupus.

Abstract 502 Panel A

Steps in the Proposed Epstein-Barr Virus (EBV)-mediated Etiology of Lupus in East Asian (EAS) and European (EU) Ancestries. aag, autoantigen. Images courtesy of NIAID {left) & Mayo Foundation {right), all rights reserved. Created with BioRender.com

Abstract 502 Panel B

P-values for the association of transcription factor (TF) DNA binding of 9,862 ChlP-seq datasets with the SLE risk loci of EAS and EU ancestries usiung RELi

Abstract 502 Panel C

Intersection plots (colored box) of EBNA2, EBNA3C, EBNALP, H3K27ac & H3K36me3 ChlP-seq datasets with SLE risk loci for EAS (upper plot) and EU (lower plot) ancestries

http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.